Related to a quinazoline compound serving as an EFGR triple mutation inhibitor and applications thereof. Specifically, disclosed are a compound as represented by the following formula (I), a pharmaceutical composition comprising the compound of formula (I), and applications of the compound in treating a related disease mediated by EGFR and in a medicament for treating the related disease mediated by EGFR.
涉及一种作为EFGR三重突变
抑制剂的
喹唑啉化合物及其应用。具体地说,公开了如下式(I)所代表的化合物、包含式(I)化合物的药物组合物,以及该化合物在治疗由
表皮生长因子受体介导的相关疾病和治疗由
表皮生长因子受体介导的相关疾病的药物中的应用。